Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

CAMCEVI KIT

LEUPROLIDE MESYLATE

Standard Dose
EQ 42MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CAMCEVI KIT is listed in Drugs@FDA under application 211488 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEUPROLIDE MESYLATE Form and strength EMULSION;SUBCUTANEOUS - EQ 42MG BASE Sponsor ACCORD Submission history Latest submission status date: 2026-02-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview CAMCEVI KIT is listed in Drugs@FDA under application 211488 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEUPROLIDE MESYLATE Form and strength EMULSION;SUBCUTANEOUS - EQ 42MG BASE Sponsor ACCORD Submission history Latest submission status date: 2026-02-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.